Japan: The land that doesn't need Ozempic
Japan’s low obesity rate is attributed less to genetics or miracle drugs like Ozempic and more to cultural norms, urban design, and lifelong food education. Commenters contrast Japan’s smaller portions, walkable cities, and social pressure around weight with the U.S. model of car dependence, large servings, ultra‑processed foods, and growing reluctance to stigmatize obesity. Several argue that while GLP‑1 drugs have real medical value, relying on them without addressing environmental and cultural drivers of obesity risks treating symptoms rather than causes.
Cultural and Social Norms
- Many argue Japan’s low obesity is primarily cultural: strong social norms, fat-shaming, and policies like “Metabo” waist checks and employer penalties create pressure to stay thin.
- Others are uncomfortable with government- or peer-enforced shame and see it as paternalistic or a “thought-police” risk, even if it works.
- Several note that norms around food, weight, and walking are deeply embedded from childhood in Japan and other East Asian countries.
Diet, Portions, and Processed Food
- Frequent contrast between Japanese/Korean smaller portions and US “supersized” meals and sides (e.g., fries, sugary drinks).
- Japan clearly has junk food, fried food, frozen convenience food, and sugary snacks, but they’re often eaten less frequently and in smaller quantities.
- Disagreement on villain: some point to “junk food” and ultra-processed foods; others emphasize sugar and sweet drinks specifically; others say overall calories (+25% in the US since the 1960s) matter most.
- US ingredients are seen as more heavily engineered (additives, HFCS, oils), though it’s unclear how much this explains obesity compared with quantity.
Walking, Urban Form, and Exercise
- Repeated theme: walkable, transit-oriented cities in Japan/Korea vs car-centric US suburbs. Just daily commuting/errands there can yield thousands of extra steps.
- Some argue walking’s calorie burn is small; others emphasize long-term cumulative effects, metabolic benefits, and appetite regulation.
- Consensus that diet dominates pure weight loss, but regular movement makes healthy eating easier and more sustainable.
Shame, Health, and Body Image
- Debate over “fat-shaming”: some see it as an effective population-level tool; others highlight mental-health harms, eating disorders, and doctor bias toward blaming weight for unrelated issues.
- Body-positivity is viewed by some as needed to counter decades of stigma; others think it downplays real health risks.
GLP‑1 Drugs (Ozempic, Wegovy, etc.)
- Some see widespread Ozempic use as symptom-treating instead of fixing food systems, culture, and urban design.
- Others stress obesity is not purely “willpower”; biology, inflammation, and appetite regulation matter, and some patients genuinely “need” GLP‑1 agonists.
- Concerns mentioned: cost, access (e.g., needing diabetes in Japan for a prescription), long-term side effects (thyroid, mood), and unclear net impact on healthcare spending.
Broader Causes and Open Questions
- Strong disagreement on root causes: lifestyle vs chemistry, environment vs personal responsibility.
- Multiple commenters caution that obesity trends are recent and multifactorial; the science is not “settled,” and simple narratives (sugar-only, walking-only, shame-only) seem incomplete.